title: Can alpha-immunotherapy succeed where other systemic modalities have failed?
authors: B J
authors: BJ
authors: Allen
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D000922:Immunotoxins; D009362:Neoplasm Metastasis / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D000922:Immunotoxins